Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cross Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel cobalt-catalyzed route offers high optical purity for pharmaceutical intermediates. Streamlined process ensures supply chain reliability and cost efficiency for global buyers.
Patent CN101475519B details a scalable route for NHE1 inhibitor intermediates, offering improved yields and supply chain reliability for cardiovascular drug manufacturing.
Patent CN108794448B reveals a high-yield Pd-catalyzed route for Trelagliptin, offering superior purity and cost efficiency for API manufacturing supply chains.
Patent CN111041515B reveals a metal-free electrochemical route for high-purity quinoxalinone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114634481B reveals copper-mediated method improving substrate scope. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110627693A reveals efficient allyl sulfone synthesis. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Novel Ni-catalyzed desulfitative coupling of sulfonyl chlorides offers high yield and broad scope. A cost-effective route for API intermediates and fine chemicals.
Novel palladium-catalyzed water-based method for asymmetric biphenyl. Reduces cost and environmental impact for pharmaceutical intermediate manufacturing.
Novel metal-free synthesis of methylthiomethyl esters using DMSO. Cost-effective, scalable pharmaceutical intermediate manufacturing with high purity standards.
Patent CN112266365A reveals a metal-free oxidative coupling method for high-purity phenoxazine intermediates, offering significant cost reduction in organic photoelectric material manufacturing.
Novel Ni-catalyzed method for trifluoroethylation using cheap 2-chloro-1,1,1-trifluoroethane. Mild conditions, high yield, suitable for pharma intermediates.
Patent CN109438402B discloses a green catalytic route for benzofuranone derivatives. High yield, low cost, scalable process ideal for pharmaceutical intermediates manufacturing.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.
Novel nitro-based cross-coupling method eliminates halogen waste. Offers cost reduction in pharmaceutical intermediate manufacturing and high-purity aromatic compounds for global supply chains.
Patent CN112174832A details a novel one-step Pd-catalyzed methylation route for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN118754905B reveals nickel catalysis for silane synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Novel 3,5-dialkyl pyrazole ligand enables C-Cl greater than C-OTf selectivity in Buchwald-Hartwig reactions, offering cost-effective pharma intermediate synthesis.
Patent CN110372544B details a cost-effective iron-titanium catalytic system for biaryl synthesis, offering significant supply chain stability and reduced environmental impact.
Patent CN112939829A reveals a copper-catalyzed method for aryl trifluoromethyl thioethers, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN108864164B details a green Pd-catalyzed method for 2-alkynyl indoles using water solvent, offering high regioselectivity and cost-effective manufacturing for pharma intermediates.